The United Kingdom (UK) withdrew completely from the European Union on December 31, 2020, and brought EU REACH into law from January 1st, 2021, as UK REACH. However, there are some amendments in CLP regulations to operate effectively in GB. Identifying the roles of suppliers (manufacturers, importers, distributors, etc), and complying with obligations of classification and labelling are the major challenges of the newly introduced GB CLP. Companies worldwide need to be aware of the changes and the new implications of the GB CLP.

What the session will cover

• Competent authorities in GB and NI

• Northern Ireland status

• CLP notification to HSE

• Labelling requirements

• Import chemicals from outside GB

Who should attend

• GB-based manufacturers, importers, downstream users 

• Distributors supplying the GB market

• Consulting companies dealing with GB-based clients

About the Presenter

Fatameh Bamdad

Fatemeh joined Yordas Group in 2019 as a Regulatory Consultant. Her work is mainly focused on global regulatory monitoring and hazard communication under FDA, TSCA, CEPA and EU REACH.

Fatemeh gained her PhD in Food science and worked in academic research labs on bioactive peptides, nutraceuticals and pharmaceuticals. She also holds a Graduate certificate in Regulatory affairs in Canada. Her professional experience includes Canada and USA drug registration process, EU and GB CLP compliance, and SDS authoring.